ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.2.
Appears in 5 contracts
Sources: Exclusive License Agreement (Ablynx NV), Exclusive License Agreement (Ablynx NV), Exclusive License Agreement (Ablynx NV)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.211.6.2.
Appears in 5 contracts
Sources: License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Aduro Biotech, Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.213.5.3.
Appears in 4 contracts
Sources: Collaboration and Option Agreement (Morphic Holding, Inc.), Collaboration and Option Agreement (Morphic Holding, Inc.), Collaboration and Option Agreement (Morphic Holding, Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.213.7.2.
Appears in 3 contracts
Sources: Collaboration Agreement (Galapagos Nv), Collaboration Agreement (Galapagos Nv), Collaboration Agreement (Galapagos Nv)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.211.5.3.
Appears in 2 contracts
Sources: License Agreement (Sionna Therapeutics, Inc.), License Agreement (Sionna Therapeutics, Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.217.6(c).
Appears in 2 contracts
Sources: Collaboration Agreement (Reata Pharmaceuticals Inc), Collaboration Agreement (Reata Pharmaceuticals Inc)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.213.6.4.
Appears in 2 contracts
Sources: License Agreement (Reata Pharmaceuticals Inc), License Agreement (Reata Pharmaceuticals Inc)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in on Schedule 13.8.213.7.3.
Appears in 2 contracts
Sources: Co Development and Option Agreement (Alector, Inc.), Co Development and Option Agreement (Alector, Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.214.7.3.
Appears in 1 contract
Sources: Discovery Collaboration and License Agreement (CytomX Therapeutics, Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.212.6.4.
Appears in 1 contract
Sources: Exclusive Option Agreement (Aldeyra Therapeutics, Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.211.7(c).
Appears in 1 contract
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.217.6(c) .
Appears in 1 contract
Sources: Collaboration Agreement (Reata Pharmaceuticals Inc)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.214.5.2.
Appears in 1 contract
Sources: Collaboration and License Agreement (REGENXBIO Inc.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.211.6.22.
Appears in 1 contract
Sources: License Agreement (Bison Capital Acquisition Corp.)
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.213.6.4 .
Appears in 1 contract
ADR. Any ADR proceeding under this Agreement shall take place pursuant to the procedures set forth in Schedule 13.8.212.5.
Appears in 1 contract